Literature DB >> 16700002

Expression of androgen-binding protein (ABP) in human cardiac myocytes.

H W Schock1, Z Herbert, H Sigusch, H R Figulla, G F Jirikowski, U Lotze.   

Abstract

Cardiomyocytes are known to be androgen targets. Changing systemic steroid levels are thought to be linked to various cardiac ailments, including dilated cardiomyopathy (DCM). The mode of action of gonadal steroid hormones on the human heart is unknown to date. In the present study, we used high-resolution immunocytochemistry on semithin sections (1 microm thick), IN SITU hybridization, and mass spectrometry to investigate the expression of androgen-binding protein (ABP) in human myocardial biopsies taken from male patients with DCM. We observed distinct cytoplasmic ABP immunoreactivity in a fraction of the myocytes. IN SITU hybridization with synthetic oligonucleotide probes revealed specific hybridization signals in these cells. A portion of the ABP-positive cells contained immunostaining for androgen receptor. With SELDI TOF mass spectrometry of affinity purified tissue extracts of human myocardium, we confirmed the presence of a 50 kDa protein similar to ABP. Our observations provide evidence of an intrinsic expression of ABP in human heart. ABP may be secreted from myocytes in a paracrine manner perhaps to influence the bioavailabity of gonadal steroids in myocardium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16700002     DOI: 10.1055/s-2006-925331

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

1.  Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study.

Authors:  Corey E Ventetuolo; Pamela Ouyang; David A Bluemke; Harikrishna Tandri; R Graham Barr; Emilia Bagiella; Anne R Cappola; Michael R Bristow; Craig Johnson; Richard A Kronmal; Jorge R Kizer; Joao A C Lima; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2010-10-01       Impact factor: 21.405

Review 2.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

3.  Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden.

Authors:  Mieke Van Hemelrijck; Jan Adolfsson; Hans Garmo; Anna Bill-Axelson; Ola Bratt; Erik Ingelsson; Mats Lambe; Pär Stattin; Lars Holmberg
Journal:  Lancet Oncol       Date:  2010-04-13       Impact factor: 41.316

4.  Associations between Peripheral Thromboembolic Vascular Disease and Androgen Deprivation Therapy in Asian Prostate Cancer Patients.

Authors:  Yu-Chuan Lu; Chao-Yuan Huang; Huei-Ming Yeh; Jian-Hua Hong; Chao-Hsiang Chang; Chih-Hsin Muo; Shiu-Dong Chung; Teng-Kai Yang; Fu-Shan Jaw; Chi-Jung Chung
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

5.  Identification, characterization and expression of novel Sex Hormone Binding Globulin alternative first exons in the human prostate.

Authors:  Tomàs Pinós; Anna Barbosa-Desongles; Antoni Hurtado; Albert Santamaria-Martínez; Inés de Torres; Joan Morote; Jaume Reventós; Francina Munell
Journal:  BMC Mol Biol       Date:  2009-06-17       Impact factor: 2.946

Review 6.  Are the adverse effects of glitazones linked to induced testosterone deficiency?

Authors:  M Carruthers; T R Trinick; E Jankowska; A M Traish
Journal:  Cardiovasc Diabetol       Date:  2008-10-15       Impact factor: 9.951

7.  Human sex hormone-binding globulin gene expression- multiple promoters and complex alternative splicing.

Authors:  Atif M Nakhla; Daniel J Hryb; William Rosner; Nicholas A Romas; Zhaoying Xiang; Scott M Kahn
Journal:  BMC Mol Biol       Date:  2009-05-05       Impact factor: 2.946

Review 8.  Classic and Novel Sex Hormone Binding Globulin Effects on the Cardiovascular System in Men.

Authors:  Carla Basualto-Alarcón; Paola Llanos; Gerardo García-Rivas; Mayarling Francisca Troncoso; Daniel Lagos; Genaro Barrientos; Manuel Estrada
Journal:  Int J Endocrinol       Date:  2021-07-21       Impact factor: 2.803

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.